CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Centogene NV is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Centogene NV
Am Strande 7
Phone: +49 38180113400p:+49 38180113400 ROSTOCK, 18055  Germany Ticker: CNTGFCNTGF
Business Summary
Centogene N.V., is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories
8099 Health and allied services, not elsewhere classified
7374 Computer processing and data preparation and processing services
7375 Information retrieval services
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board Peer M.Schatz 59 1/1/2021 3/16/2020
Chief Executive Officer, Managing Director, Member of the Management Board KimStratton 62 2/1/2022 2/1/2022
Vice Chairman of the Supervisory Board AndreasBusch 60 2/18/2022 2/18/2022
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Centogene d.o.o Belgrade
Centogene FZ-LLC
Centogene GmbH
7 additional Business Names available in full report.

General Information
Number of Employees: 493 (As of 12/31/2023)
Outstanding Shares: 27,595,835 (As of 12/31/2023)
Shareholders: 23
Stock Exchange: OTC
Fax Number: +49 38180113401


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024